ANRG -- Anergen -- new CEO big chance ? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANRG -- Anergen -- new CEO big chance ?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tonyt who wrote (71)	2/9/1998 7:11:00 PM
From: tonyt	Read Replies (1) of 123

REDWOOD CITY, Calif., Feb 9 (Reuters) - Anergen Inc said Monday its had cut it work force to 60 from 75. The company said in a statement the job cuts were needed to reduce the company's burn rate -- the amount of money a biotech firm spends while it is not making profits. Anergen also said its collaboration with Novo Nordisk (NYSE:NVO) will be terminated, with all rights returning to Anergen. Novo Nordisk will reimburse Anergen for the cost of the ongoing multiple sclerosis Phase I clinical trial which will be completed in the third quarter of 1998. Anergen reported a fourth quarter net loss of $2.4 million, or $0.13 a share, on revenues of $1.4 million compared to a loss of $2.4 million, or $0.13 a share on revenues of $1.46 million in the comparable year-ago quarter. Copyright 1998, Reuters News Service

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next